121 related articles for article (PubMed ID: 476893)
1. Platelet suppressant therapy in patients with prosthetic cardiac valves. Relationship of clinical effectiveness to alteration of platelet survival time.
Steele P; Rainwater J; Vogel R
Circulation; 1979 Oct; 60(4):910-3. PubMed ID: 476893
[TBL] [Abstract][Full Text] [Related]
2. Platelet survival time following aortic valve replacement.
Steele P; Weily H; Davies H; Ppppas G; Genton E
Circulation; 1975 Feb; 51(2):358-62. PubMed ID: 1112016
[TBL] [Abstract][Full Text] [Related]
3. Platelet-suppressant therapy in patients with coronary artery disease.
Steele P; Rainwater J; Vogel R; Genton E
JAMA; 1978 Jul; 240(3):228-31. PubMed ID: 307069
[TBL] [Abstract][Full Text] [Related]
4. Effect of sulfinpyrazone on platelet survival time in patients with transient cerebral ischemic attacks.
Steele P; Carroll J; Overfield D; Genton E
Stroke; 1977; 8(3):396-8. PubMed ID: 871029
[TBL] [Abstract][Full Text] [Related]
5. Platelet survival time and thromboembolism in patients with mitral valve prolapse.
Steele P; Weily H; Rainwater J; Vogel R
Circulation; 1979 Jul; 60(1):43-5. PubMed ID: 445732
[TBL] [Abstract][Full Text] [Related]
6. Effects of clofibrate and sulfinpyrazone on platelet survival time in coronary artery disease.
Steele P; Battock D; Genton E
Circulation; 1975 Sep; 52(3):473-6. PubMed ID: 1157247
[TBL] [Abstract][Full Text] [Related]
7. Platelet survival in patients with substitute heart valves.
Weily HS; Steele PP; Davies H; Pappas G; Genton E
N Engl J Med; 1974 Mar; 290(10):534-7. PubMed ID: 4811097
[No Abstract] [Full Text] [Related]
8. Failure of sulphinpyrazone to affect platelet survival in patients with rheumatic heart valvular disease: a double blind study using 75Se-methionine labeled platelets.
Fabris F; Casonato A; Randi ML; Schivazappa L; Schiavinato L; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(4):594-601. PubMed ID: 6196274
[TBL] [Abstract][Full Text] [Related]
9. Effects of dietary and pharmacologic alteration of serum lipids on platelet survival time.
Steele P; Rainwater J
Circulation; 1978 Aug; 58(2):365-7. PubMed ID: 668086
[TBL] [Abstract][Full Text] [Related]
10. Altered platelet function in patients with prosthetic mitral valves. Effects of sulfinpyrazone therapy.
Weily HS; Genton E
Circulation; 1970 Nov; 42(5):967-72. PubMed ID: 5477265
[No Abstract] [Full Text] [Related]
11. Favorable effect of sulfinpyrazone on thromboembolism in patients with rheumatic heart disease.
Steele P; Rainwater J
Circulation; 1980 Sep; 62(3):462-5. PubMed ID: 7398003
[No Abstract] [Full Text] [Related]
12. Platelet inhibition in the management of thrombosis.
Didisheim P; Kazmier FJ; Fuster V
Thromb Diath Haemorrh; 1974 Sep; 32(1):21-34. PubMed ID: 4616423
[TBL] [Abstract][Full Text] [Related]
13. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
ElBardissi AW; DiBardino DJ; Chen FY; Yamashita MH; Cohn LH
J Thorac Cardiovasc Surg; 2010 May; 139(5):1137-45. PubMed ID: 20303508
[TBL] [Abstract][Full Text] [Related]
14. Effect of athrombogenic therapy, especially high dose therapy of dipyridamole, after prosthetic valve replacement.
Taguchi K; Matsumura H; Washizu T; Harao M; Kato K; Kato E; Mochizuki T; Takamura K; Mashimo I; Mirifuji K; Nakagaki M; Suma T
J Cardiovasc Surg (Torino); 1975; 16(1):8-15. PubMed ID: 1126989
[TBL] [Abstract][Full Text] [Related]
15. Platelet survival and function in animals with prosthetic mitral valve: the effect of nafazatrom.
Al-Mondhiry H; Pierce WS; Richenbacher W
Thromb Haemost; 1984 Oct; 52(2):99-101. PubMed ID: 6523440
[TBL] [Abstract][Full Text] [Related]
16. Proceedings: Comparative effects of platelet suppressant drugs on platelet survival time.
Genton E; Ellis J; Steele P
Thromb Diath Haemorrh; 1975 Nov; 34(2):552. PubMed ID: 1198422
[No Abstract] [Full Text] [Related]
17. Plasma heparin neutralizing activity in patients with valvular stenosis and prosthetic heart valves.
Dana B; Ellman L; Carvalho A; Daggett WM
J Cardiovasc Surg (Torino); 1977; 18(1):29-34. PubMed ID: 833188
[TBL] [Abstract][Full Text] [Related]
18. Platelet survival in patients with rheumatic heart disease.
Steele PP; Weily HS; Davies H; Genton E
N Engl J Med; 1974 Mar; 290(10):537-9. PubMed ID: 4811098
[No Abstract] [Full Text] [Related]
19. Platelet malondialdehyde in cardiovascular disease: effect of prosthetic heart valves and cardioactive drugs on production.
Sullivan JM; Taylor JC; Samaha JK
Thromb Haemost; 1980 Oct; 44(2):76-80. PubMed ID: 7455995
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease.
Ribeiro PA; Al Zaibag M; Idris M; Al Kasab S; Davies G; Mashat E; Wareham E; Al Fagih M
J Thorac Cardiovasc Surg; 1986 Jan; 91(1):92-8. PubMed ID: 3941564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
